Startup receives grant to develop breast cancer treatment
Huppert Discusses Later-Line Therapy Decisions in HR+, HER2β Metastatic Breast Cancer
Friedman Center for Breast & Lymphatics Surgery
Home Triple Negative Breast Cancer Foundation
Home Triple Negative Breast Cancer Foundation
Protecting bone health after treatment is an important part of breast cancer survivorship. In our latest blog, we offer tips to proactive
Home Triple Negative Breast Cancer Foundation
Breast Cancer Conference Addresses HER2-Low Therapeutic Subset
YES1 Inhibitors: A Game-Changer in Triple-Negative Breast Cancer Treatment